COVID-19

Approximately 1 out of every 6 patients with COVID-19 had a reduced eGFR.

New cohort analysis data suggest the risk of COVID-19 death is about 38% decreased among patients with the autoimmune disease.

In a late-breaking abstract, the investigators compared antibody levels at month 6 compared to month 1.

Jacinda Abdul-Mutakabbir, PharmD, discusses the difference between the original SARS-CoV-2 strain and subvariant strains.

The glycemic gap was a stronger predictor of in-hospital mortality among adults with diabetes or hyperglycemia hospitalized for COVID-19.

Paxlovid is effective in patients with existing heart disease, but has significant DDIs with commonly used cardiovascular medications.

A discussion regarding highlights from Dr. Michael Angarone’s presentation on emerging infectious diseases.

A recent study confirmed the safety of tralokinumab with regard to COVID-19 and related vaccinations.

A profound escalation in the frequency of nightmares, independently associated with suicide risk, occurred alongside related sleep and mental health outcomes during the COVID-19 pandemic.

The majority of patients treated with systemic therapies were treated with dupilumab, while 3.2% patients received a combination of systemic therapies.

Conflicting evidence on the risks associated with intubation in patients with COVID-19 initiated a debate in the medical community regarding the benefit of utilizing high-flow oxygen.

Patients with both COVID-19 and HBV had a significantly higher in-hospital mortality rate and were more likely to develop severe disease compared to patients with only COVID-19 infections.

There were 248 patients included in the study with genetic data, with no differences found in mean titer after 2 or 3 doses between carriers and non-carriers of HLA-A24 associated with severe disease during COVID-19 infections.

The pandemic may have both widened the vaccination coverage gap between rural and urban adolescents and affected vaccination coverage in general.

CDC investigators stated that the expansion of telehealth strategies is “urgently needed” to provide medications for opioid use disorder because it could increase retention in care and improve outcomes for OUD.

Recent research from George Washington University analyzed the effects of COVID-19 on recruitment and funding for medical school pathway programs.

Full-dose anticoagulation, but not clopidogrel, reduced thrombotic complications in critically-ill patients with COVID-19.

Hybrid visits were primarily for glaucoma (45.1%) and retinal issues (53.1%).

Vaccine-associated myocarditis was largely restricted to men younger than 40 years, according to the new findings.

Dr. Shear talked about the similarities and differences between depression and grief and the importance of recognizing both.

The findings suggest access to the vaccine was lowest among those who reported blindness, deafness, or multiple disabilities.

The screening of more than 50,000 youth patients in diverse populations of Colorado and Bavaria, Germany reported no association between infection and T1D.

Investigators from found that 12.12% of patients with a previous skin disease diagnosis developed an adverse skin reaction following a COVID-19 vaccine injection.

The association with depressive symptoms was greater when race, ancestry, or national origins among Hispanic or Latino participants was the main reason for discrimination.

An analysis of survey responses show tolerance toward public health official harassment and threatening has worsened since 2020.